RecruitingNCT06797934

Establishment of a Registry of Patients With Parathyroid Disease

Sponsor

IRCCS Azienda Ospedaliero-Universitaria di Bologna

Enrollment

1,200 participants

Start Date

Jan 3, 2022

Study Type

OBSERVATIONAL

Conditions

Hypoparathyroidism Hyperparathyroidism

Summary

Establishment of a registry with which to census all patients under the care of the O.U. Endocrinology for parathyroid pathology in order to longitudinally evaluate biochemical, clinical, radiological, medico-nuclear and histological data in future studies.

Eligibility

Min Age: 18 Years

Inclusion Criteria3

Age ≥18 years
Diagnosis of hyperparathyroidism or hypoparathyroidism based on biochemical parameters (calcemia, parathormone, phosphormia, creatinine, albumin, vitamin D25OH)
Obtaining informed consent

Exclusion Criteria1

none

Print for Your Doctor

Interested in this trial?

Get notified about updates and connect with the research team.

Locations(1)

IRCCS Azienda Ospedaliero-Universitaria di Bologna

Bologna, Bologna, Italy

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06797934

Related Trials

Efficacy and Safety of XH02 for the Treatment of Hypoparathyroidism

NCT071974501 location

A Global Pregnancy Registry to Assess Maternal, Fetal, and Infant Outcomes Following Exposure to YORVIPATH® (Palopegteriparatide) During Pregnancy and Breastfeeding

NCT073454941 location